Plasma growth hormone GH responses to corticotropin-releasing hormone in patients with acromegaly-the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing...


     Related Videos
Secretropin A Growth Hormone Secretagogue - Mark Gordon MD
Human Growth Hormone
  • Human Growth Hormone

  • Stay young and healthy with HGH Are You Feeling Low on Energy? Do You see Wrinkles when You look in ...

Secretropin A Growth Hormone Secretagogue - Mark Gordon MD
Testosterone DHT Growth Hormone and IGF1 and the Potential Risk for Cancer - Dr Mark Gordo...
Testosterone DHT Growth Hormone and IGF1 and the Potential Risk for Cancer - Dr Mark Gordo...

     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      Views: (1056)   Date: (27-01-09)   Pages: ()
    • Author:  Utsumi A  Hanew K  Sugawara A  Shimizu Y  Murakami O  Ikeda H  Yoshinaga K.  

    • Abstract:  Plasma growth hormone (GH) responses to corticotropin-releas ing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasin g hormone, gonadotropin-releasi ng hormone and GH-releasing hormone. Utsumi A, Hanew K, Sugawara A, Shimizu Y, Murakami O, Ikeda H, Yoshinaga K. Second Department of Internal Medicine, Tohoku University, Sendai, Japan. It has been reported that paradoxical GH responses to corticotropin-releas ing hormone (CRH) occur in only few patients with acromegaly. However, we have observed such responses in 7 of 14 active acromegalic patients. Therefore, we have studied the GH responses to thyrotropin-releasin g hormone (TRH) (500 micrograms, iv), gonadotropin-releasi ng hormone (LHRH) (100 micrograms, iv) and GH-releasing hormone (GHRH) (100 micrograms, iv) in these patients to examine the relationships between the GH responses to CRH and the responses to these hypothalamic hormones. Further, these patients received human CRH (1-41) NH2 (100 micrograms, iv) with or without dexamethasone (Dex) pretreatment (1 mg/100 ml saline, iv, from -30 to +30 min) to study the mechanism of CRH-induced GH secretion, and a perifusion experiment was performed using adenoma tissue obtained at surgery from one patient (10(-7) M CRH and TRH were added) to elucidate whether CRH acts directly at the pituitary level. Aberrant GH responses induced by CRH were found in 7 of 14 (50%) acromegalic patients (TRH responders: 10/13, 77%; LHRH responders: 2/9, 22%; GHRH responders: 10/12, 83%). In these patients, percent GH increment induced by CRH ranged from 81 to 144% (Mean +/- SE, 118 +/- 8%), and the GH peak (19 +/- 3 min) appeared as early as after TRH (23 +/- 4 min, N = 10).(ABSTRACT TRUNCATED AT 250 WORDS) PMID: 1624675 [PubMed - indexed for MEDLINE]

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

               Answers

               News

               Related on Wikipedia




























           

          Powered free by PHPmotion